*  S0337, Gemcitabine After Surgery in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer - Full Text View -...
Urinary Bladder Neoplasms. Urologic Neoplasms. Urogenital Neoplasms. Neoplasms by Site. Neoplasms. Urinary Bladder Diseases. ... transitional cell carcinoma of the bladder. stage 0 bladder cancer. stage I bladder cancer. recurrent bladder cancer. ... Grade 1 or 2 disease (similar to papillary urothelial neoplasm of low malignant potential and low-grade bladder cancer) ... It is not yet known whether giving gemcitabine directly into the bladder is more effective than a placebo in treating bladder ...
  https://clinicaltrials.gov/ct2/show/study/NCT00445601?show_locs=Y
*  A Study of ALT-801 in Patients With Bacillus Calmette-Guerin (BCG) Failure Non-Muscle Invasive Bladder Cancer - Full Text View ...
Urinary Bladder Neoplasms. Urologic Neoplasms. Urogenital Neoplasms. Neoplasms by Site. Neoplasms. Urinary Bladder Diseases. ... This is largely because approximately 70% of all new cases of bladder cancer present as non-muscle invasive bladder cancer ( ... bladder cancer. HLA-A2 positive. HLA-A*0201/p53 aa264-272. HLA complex. refractory. relapsed. BCG. multi-focal. carcinoma in ... Non-muscle Invasive Bladder Cancer Biological: ALT-801 Drug: Gemcitabine Phase 1 Phase 2 ...
  https://clinicaltrials.gov/ct2/show/study/NCT01625260?show_desc=Y
*  Plasmacytoid urothelial carcinoma of the urinary bladder: a clinical pathological study and literature review.
Plasmacytoid carcinoma of the urinary bladder or plasmacytoid urothelial carcinoma (PUC) is a rare and only recently described ... Retroperitoneal Neoplasms / secondary. Tumor Markers, Biological / metabolism. Urinary Bladder Neoplasms / metabolism, ... Previous Document: Small cell carcinoma of the urinary bladder.. Next Document: Late recurrence of sigmoid carcinoma mimicking ... PURPOSE: Plasmacytoid carcinoma of the urinary bladder or plasmacytoid urothelial carcinoma (PUC) is a rare and only recently ...
  http://www.biomedsearch.com/nih/Plasmacytoid-urothelial-carcinoma-urinary-bladder/22949945.html
*  Compound Report Card
SKIN NEOPLASMS. D012878. EFO:0004198. SKIN NEOPLASM. 2. ClinicalTrials. URINARY BLADDER NEOPLASMS. D001749. EFO:0000292. ... NEOPLASMS. D009369. EFO:0000616. NEOPLASM. 4. ATC. ClinicalTrials. ESOPHAGEAL NEOPLASMS. D004938. EFO:0002916. ESOPHAGEAL ... BRAIN NEOPLASMS. D001932. EFO:0003833. BRAIN NEOPLASM. 2. ClinicalTrials. CARCINOMA, RENAL CELL. D002292. EFO:0000681. RENAL ... BREAST NEOPLASMS. D001943. EFO:0000305. BREAST CARCINOMA. 2. ClinicalTrials. ClinicalTrials. NEOPLASMS. D009369. EFO:0000311. ...
  https://www.ebi.ac.uk/chembldb/compound/inspect/CHEMBL553
*  A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer - Full Text...
Neoplasms. Ureteral Neoplasms. Urinary Bladder Neoplasms. Urethral Neoplasms. Kidney Neoplasms. Carcinoma. Neoplasms, Glandular ... Urologic Neoplasms. Urogenital Neoplasms. Neoplasms by Site. Ureteral Diseases. Urologic Diseases. Urinary Bladder Diseases. ... Bladder cancer is the fourth most common malignancy in men and the ninth most common in women in the US, with an estimated ... bladder cancer. renal pelvis cancer. ureters cancer. urethra cancer. HLA-A2 positive. HLA-A*0201/p53 aa264-272. HLA complex. ...
  https://clinicaltrials.gov/ct2/show/NCT01326871?recr=Open&cond=%22Urethral+Neoplasms%22&rank=9
*  The Molecular Predisposition to Hereditary Nonpolyposis Colon Cancer (HNPCC) - Full Text View - ClinicalTrials.gov
Colonic Neoplasms. Urinary Bladder Neoplasms. Endometrial Neoplasms. Kidney Neoplasms. Carcinoma, Renal Cell. Skin Neoplasms. ... Uterine Neoplasms. Intestinal Neoplasms. Gastrointestinal Neoplasms. Digestive System Neoplasms. Neoplasms by Site. Neoplasms. ... Urologic Neoplasms. Urogenital Neoplasms. Urinary Bladder Diseases. Urologic Diseases. Genital Neoplasms, Female. Uterine ... Bladder Cancer Colorectal Cancer Endometrial Cancer Kidney Cancer Skin Cancer Uterus Cancer Behavioral: Health and Diet ...
  https://clinicaltrials.gov/ct2/show/NCT01447199?term=NCT01447199&rank=1
*  Search of: Electrocardiogram | Recruiting, Not yet recruiting, Available Studies | NIH, U.S. Fed - List Results -...
Urinary Bladder Neoplasms. *Drug: Durvalumab. *Drug: Vicinium. Interventional. Phase 1. *National Cancer Institute (NCI) ... Durvalumab and Vicinium in Subjects With High-Grade Non-Muscle-Invasive Bladder Cancer Previously Treated With Bacillus ...
  https://clinicaltrials.gov/ct2/results?term=Electrocardiogram&recr=Open&fund=01&show_flds=Y
*  Trial to Evaluate Paclitaxel Plus RAD001 in Urothelial Carcinoma - Full Text View - ClinicalTrials.gov
Urinary Bladder Neoplasms. Carcinoma, Transitional Cell. Urologic Neoplasms. Urogenital Neoplasms. Neoplasms by Site. Neoplasms ... Urinary Bladder Diseases. Urologic Diseases. Carcinoma. Neoplasms, Glandular and Epithelial. Neoplasms by Histologic Type. ... Patients with histologically proven carcinoma of the urinary tract including urinary bladder, ureter, renal pelvis and lower ... trial evaluating safety and efficacy of paclitaxel and RAD001 in patients with metastatic urothelial bladder cancer who failed ...
  https://clinicaltrials.gov/ct2/show/NCT00933374
*  Safety and Tolerability Study Which Evaluate Intravesical Instillation With Mitomycin C Mixed With TC-3 Drug Retaining Hydrogel...
Urinary Bladder Neoplasms. Urologic Neoplasms. Urogenital Neoplasms. Neoplasms by Site. Neoplasms. Urinary Bladder Diseases. ... Non Muscle Invasive Bladder Cancer. Carcinoma of urinary bladder, invasive. Intravesical instillation. Mitomycin C. Hydrogel. ... Carcinoma of Urinary Bladder, Invasive Device: TC-3 gel Device: TC-3 gel mixed with Mitomycin C (MMC) ... Assessment of the levels of MMC in patients urinary bladder following intravesical instillation of TC-3 mixed with MMC. [ Time ...
  https://clinicaltrials.gov/ct2/show/NCT01648010
*  Effect of Dietary, Lifestyle, and Environmental Factors on Patients With Early-Stage Bladder Cancer - Full Text View -...
Urinary Bladder Neoplasms. Urologic Neoplasms. Urogenital Neoplasms. Neoplasms by Site. Neoplasms. Urinary Bladder Diseases. ... stage 0 bladder cancer. stage I bladder cancer. transitional cell carcinoma of the bladder. ... Bladder Cancer Procedure: medical chart review Procedure: questionnaire administration Procedure: study of socioeconomic and ... Effect of Dietary, Lifestyle, and Environmental Factors on Patients With Early-Stage Bladder Cancer. The recruitment status of ...
  https://clinicaltrials.gov/ct2/show/NCT00553566
*  Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer -...
Neoplasms by Histologic Type. Neoplasms. Urologic Neoplasms. Urogenital Neoplasms. Neoplasms by Site. Urinary Bladder Diseases ... Urinary Bladder Neoplasms. Carcinoma, Transitional Cell. Prostatic Neoplasms. Urethral Neoplasms. Kidney Neoplasms. Ureteral ... Bladder Urothelial Carcinoma Distal Urethral Carcinoma Infiltrating Bladder Urothelial Carcinoma Associated With Urethral ... carcinoma of the urinary tract (renal pelvis, ureter, bladder, prostate, or urethra), with metastatic or locally advanced ...
  https://clinicaltrials.gov/ct2/show/study/NCT00942331?view=record
*  Measurement of Gemcitabine Metabolites in Blood and Urine as Predictors of Response to GemX Bladder Radiotherapy - Full Text...
Urinary Bladder Neoplasms. Urologic Neoplasms. Urogenital Neoplasms. Neoplasms by Site. Neoplasms. Urinary Bladder Diseases. ... Measurement of Gemcitabine Metabolites in Blood and Urine as Predictors of Response to GemX Bladder Radiotherapy (Gemtrans). ... Measurement of Gemcitabine Metabolites in Blood and Urine as Predictors of Response to GemX Bladder Radiotherapy. ... No previous treatment for diagnosis of muscle-invasive bladder cancer or other pelvic radiotherapy. ...
  https://clinicaltrials.gov/ct2/show/NCT01343121
*  Search of: aspirin | Studies with Male Participants - List Results - ClinicalTrials.gov
Urinary Bladder Neoplasms. *Drug: Aspirin. Interventional. Phase 4. *Rabin Medical Center. Other. *Allocation: Randomized ... Serum thromboxane B2 concentration Urinary 11-dehydro thromboxane B2 concentration Urinary 2,3 dinor-6 keto PGF1α concentration ... Urinary Thromboxane B2/Creatinine Ratio. 160. All. 18 Years and older (Adult, Senior). NCT02970604. RCSIMCT20152017. May 2016. ... Urinary and blood inflammatory biomarkers. 50. All. 50 Years to 75 Years (Adult, Senior). NCT02761486. 1604M86161. 2016NTLS049 ...
  https://clinicaltrials.gov/ct2/results?term=aspirin&state1=NA%3AUS%3ANY&gndr=Male&show_down=Y
*  Comparison of Standard of Care or Treatment on Protocol - Full Text View - ClinicalTrials.gov
Stomach Neoplasms. Uterine Neoplasms. Urologic Neoplasms. Urogenital Neoplasms. Neoplasms by Site. Neoplasms. Urinary Bladder ... Urinary Bladder Neoplasms. Esophageal Neoplasms. Skin Neoplasms. ... Digestive System Neoplasms. Head and Neck Neoplasms. Digestive ... Stomach Cancer Esophageal Cancer Bladder Cancer Skin Cancer Lung Cancer Uterine Cancer Ovarian Cancer Other: standard of care ...
  https://clinicaltrials.gov/ct2/show/study/NCT01010334?view=results
*  Search of: Recruiting, Not yet recruiting, Available Studies | 'Neoplasms' - List Results - ClinicalTrials.gov
Irreversible Electroporation(IRE) For Unresectable Urinary Bladder Neoplasms. *Urinary Bladder Neoplasms. *Procedure: ... Urinary Bladd Neoplasms-IRE-01. IRE. January 2015. January 2017. January 2020. April 30, 2015. March 29, 2016. *Biological ... Malignant Genito-urinary Tumors in Children: South Egypt Cancer Institute Experience. *Genitourinary Neoplasms ... Lifestyle Intervention for Prevention of Gastric Neoplasm. *Stomach Neoplasms. *Behavioral: Active measures of lifestyle ...
  https://clinicaltrials.gov/search/open/condition=%22Neoplasms%22
*  Neoadjuvant Dose Dense Gemcitabine and Cisplatin (DD GC) In Patients With Muscle-Invasive Bladder Cancer - Full Text View -...
Urinary Bladder Neoplasms. Urologic Neoplasms. Urogenital Neoplasms. Neoplasms by Site. Neoplasms. Urinary Bladder Diseases. ... Neoadjuvant Dose Dense Gemcitabine and Cisplatin (DD GC) In Patients With Muscle-Invasive Bladder Cancer. The safety and ... Phase II Study of Neoadjuvant Dose Dense Gemcitabine and Cisplatin (DD GC) In Patients With Muscle-Invasive Bladder Cancer. ... Muscle invasive urothelial carcinoma of the bladder histologically confirmed at MSKCC or participating site ((Urothelial ...
  https://clinicaltrials.gov/ct2/show/NCT01589094
*  A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer - Full Text View ...
Urinary Bladder Neoplasms. Carcinoma, Transitional Cell. Urologic Neoplasms. Urogenital Neoplasms. Neoplasms by Site. Urinary ... Urologic Neoplasms Metastatic Bladder Cancer Urinary Tract Neoplasms Drug: OGX-427 600 mg Drug: OGX-427 1000 mg Drug: Placebo ... Neoplasms, Glandular and Epithelial. Neoplasms by Histologic Type. Gemcitabine. Cisplatin. Carboplatin. Antineoplastic Agents. ... A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer. The safety and ...
  https://clinicaltrials.gov/ct2/show/NCT01454089
*  Selenium in Preventing Cancer Recurrence in Patients With Bladder Cancer - Full Text View - ClinicalTrials.gov
Urinary Bladder Neoplasms. Recurrence. Urologic Neoplasms. Urogenital Neoplasms. Neoplasms by Site. Neoplasms. Urinary Bladder ... stage 0 bladder cancer. stage I bladder cancer. transitional cell carcinoma of the bladder. ... in preventing the recurrence of bladder cancer in patients with non-muscle-invasive transitional cell carcinoma of the bladder ... Selenium in Preventing Cancer Recurrence in Patients With Bladder Cancer (SELEBLAT). The safety and scientific validity of this ...
  https://clinicaltrials.gov/ct2/show/NCT00729287
*  Gemcitabine, Cisplatin, Plus Lenalidomide as First-line Therapy for Patients With Metastatic Urothelial Carcinoma - Full Text...
Neoplasms by Histologic Type. Neoplasms. Urologic Neoplasms. Urogenital Neoplasms. Neoplasms by Site. Urinary Bladder Diseases ... Urinary Bladder Neoplasms. Carcinoma. Neoplasms, Glandular and Epithelial. ... Urothelial carcinoma of the urinary bladder is the second most common genitourinary malignancy. Based on the results of a large ... The primary objectives of this study are (Phase 1) to determine in subjects with unresectable or metastatic bladder cancer who ...
  https://clinicaltrials.gov/ct2/show/NCT01342172
*  Combination Chemotherapy in Treating Patients With Bladder Cancer - Full Text View - ClinicalTrials.gov
Urinary Bladder Neoplasms. Carcinoma, Transitional Cell. Urologic Neoplasms. Urogenital Neoplasms. Neoplasms by Site. Neoplasms ... Urinary Bladder Diseases. Urologic Diseases. Carcinoma. Neoplasms, Glandular and Epithelial. Neoplasms by Histologic Type. ... stage III bladder cancer. stage IV bladder cancer. transitional cell carcinoma of the bladder. ... Bladder Cancer Biological: filgrastim Drug: cisplatin Drug: doxorubicin hydrochloride Drug: gemcitabine hydrochloride Phase 3 ...
  https://clinicaltrials.gov/show/NCT00014534%A0
*  Tamoxifen for Progressive Transitional Cell Carcinoma Following Previous Chemotherapy Treatment - Tabular View - ClinicalTrials...
Urinary Bladder Neoplasms. Intervention ICMJE Drug: Tamoxifen Tamoxifen is administered at 20 mg/day as a single daily oral ... Expression of estrogen receptors-alpha and -beta in bladder cancer cell lines and human bladder tumor tissue. Cancer. 2006 Jun ... Patients previously diagnosed with bladder cancer who have already received 1-2 systemic therapy regimens (chemotherapy or ... of this two-stage phase II study is to determine whether tamoxifen is deserving of further study in metastatic bladder cancer. ...
  https://clinicaltrials.gov/ct2/show/record/NCT00589017
*  Carboplatin and Gemcitabine Hydrochloride With or Without Vandetanib as First-Line Therapy in Treating Patients With Locally...
Kidney Neoplasms. Ureteral Neoplasms. Urologic Neoplasms. Urogenital Neoplasms. Neoplasms by Site. Neoplasms. Urinary Bladder ... Urinary Bladder Neoplasms. Urethral Neoplasms. Carcinoma, Transitional Cell. ... transitional cell carcinoma of the bladder. stage III bladder cancer. stage IV bladder cancer. anterior urethral cancer. ... Neoplasms, Glandular and Epithelial. Neoplasms by Histologic Type. Kidney Diseases. Ureteral Diseases. Gemcitabine. Carboplatin ...
  https://clinicaltrials.gov/ct2/show/NCT01191892?recr=Open&cond=%22Ureteral+Neoplasms%22&rank=13
*  Intravesical Gemcitabine Instillation Followed by Transurethral Resection for the Treatment of Patients With Superficial...
Urinary Bladder Neoplasms. Urologic Neoplasms. Urogenital Neoplasms. Neoplasms by Site. Neoplasms. Urinary Bladder Diseases. ... low risk superficial bladder cancer.After diagnostic urethrocystoscopy or bladder sonography, all patients will receive ... Primary solitary bladder tumour not exceeding 2 cm of diameter at sonography and/or at cystoscopy, judged by the investigator ... Transitional carcinoma of the upper urinary tract and prostatic urethra.. *Any previous or concomitant malignancy other than ...
  https://clinicaltrials.gov/ct2/show/NCT00191711
*  Search of: Kaiser Permanente | Recruiting, Not yet recruiting, Available Studies | cancer - List Results - ClinicalTrials.gov
Urinary Bladder Neoplasms. *Urologic Neoplasms. *(and 4 more...). *Drug: Enfortumab vedotin. Interventional. Phase 2. *Astellas ... Also searched for Neoplasm, Tumor, and Neoplastic syndrome. See Search Details. Applied Filters: Recruiting Not yet recruiting ... A Study of Enfortumab Vedotin for Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer. *Carcinoma, ...
  https://clinicaltrials.gov/ct2/results?term=Kaiser+Permanente&recr=Open&cond=cancer&show_rss=Y
*  A Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer (Cohort 2) - Full Text...
Urinary Bladder Neoplasms. Urologic Neoplasms. Urogenital Neoplasms. Neoplasms by Site. Neoplasms. Urinary Bladder Diseases. ... A Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer (Cohort 2). The safety ... Malignancies other than urothelial bladder cancer within 5 years prior to Cycle 1, Day 1, with the exception of those with a ... A Phase II, Multicenter, Single-Arm Study of Atezolizumab in Patients With Locally Advanced or Metastatic Urothelial Bladder ...
  https://clinicaltrials.gov/ct2/show/study/NCT02108652